Literature DB >> 8026242

Chronic ulcerative colitis associated with malignant disease. 1928.

J A Bargen.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8026242     DOI： 10.1007/bf02054420

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN： 0012-3706            Impact factor:   4.585


× No keyword cloud information.
  7 in total

Review 1.  Has the risk of colorectal cancer in inflammatory bowel disease decreased?

Authors:  Nynne Nyboe Andersen; Tine Jess
Journal:  World J Gastroenterol       Date:  2013-11-21       Impact factor: 5.742

2.  Toll-like receptor 5 and 7 expression in adenoid cystic carcinoma of major salivary glands.

Authors:  K Hirvonen; L Bäck; C Haglund; I Leivo; L Jouhi; A A Mäkitie; J Hagström
Journal:  Tumour Biol       Date:  2016-02-18

3.  Association between Toll-like receptor 7 Gln11Leu single-nucleotide polymorphism and basal cell carcinoma.

Authors:  Irene Russo; Camilla Cona; Andrea Saponeri; Franco Bassetto; Vincenzo Baldo; Mauro Alaibac
Journal:  Biomed Rep       Date:  2016-02-15

4.  Composite lymphoma in a patient with ulcerative colitis: a case report.

Authors:  Farzaneh Ashrafi; Farid Kowsari; Ali Darakhshandeh; Peyman Adibi
Journal:  Int J Hematol Oncol Stem Cell Res       Date:  2014-10-01

Review 5.  Different Toll-Like Receptor Expression Patterns in Progression toward Cancer.

Authors:  Lauri Jouhi; Suvi Renkonen; Timo Atula; Antti Mäkitie; Caj Haglund; Jaana Hagström
Journal:  Front Immunol       Date:  2014-12-15       Impact factor: 7.561

Review 6.  Use and barriers to chromoendoscopy for dysplasia surveillance in inflammatory bowel disease.

Authors:  Richa Shukla; Mark Salem; Jason K Hou
Journal:  World J Gastrointest Endosc       Date:  2017-08-16

7.  Combinatorial treatment with polyI:C and anti-IL6 enhances apoptosis and suppresses metastasis of lung cancer cells.

Authors:  Wai Hoe Lau; Xiphias Ge Zhu; Shamaine Wei Ting Ho; Shu Chun Chang; Jeak Ling Ding
Journal:  Oncotarget       Date:  2017-05-16
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.